Ҵý

Feature Channels: Pharmaceuticals

Filters close
Go to Advanced Search
Released: 2-May-2025 6:45 PM EDT
A New Metric to Identify—and Prevent—Pharmacy Deserts
Yale School of Medicine

Local pharmacies fill more than 90% of prescriptions in the United States, making them essential for much of the population. They’re also key providers of vaccines and services such as medication management.

Ҵý: One Timed-release Capsule Could Replace Taking Multiple Pills
Released: 1-May-2025 5:25 PM EDT
One Timed-release Capsule Could Replace Taking Multiple Pills
University of California San Diego

Managing complex medication schedules could soon become as simple as taking a single capsule each day. Engineers have developed a capsule that can be packed with multiple medications and release them at designated times throughout the day, potentially reducing the risk of missed doses or accidental overdoses.

Ҵý: UNC Researchers Uncover Molecular Mechanism Behind Hydralazine-Induced ANCA Vasculitis
Released: 1-May-2025 4:50 PM EDT
UNC Researchers Uncover Molecular Mechanism Behind Hydralazine-Induced ANCA Vasculitis
University of North Carolina School of Medicine

Investigators at the UNC School of Medicine have gained a clearer understanding of what causes the rare autoimmune condition that inflames blood vessels.

Ҵý: Broader Antibiotic Use Could Change the Course of Cholera Outbreaks, Research Suggests
Released: 29-Apr-2025 8:00 PM EDT
Broader Antibiotic Use Could Change the Course of Cholera Outbreaks, Research Suggests
University of Utah Health

New modeling research challenges public health guidelines that recommend conservative antibiotic use for cholera. In some cases, prescribing antibiotics more broadly could slow or stop outbreaks and even reduce the risk of antibiotic resistance.

Released: 25-Apr-2025 7:40 PM EDT
Eight Early-Career Scientists Will Attend the AACR Annual Meeting with Ludwig Support
Ludwig Cancer Research

Ludwig Cancer Research is proud to support eight early-career scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards (SITA) program, contributing to the cost of their travel and attendance at the conference.

Not for public release

This news release is embargoed until 21-Apr-2025 5:00 PM EDT Released to reporters: 15-Apr-2025 8:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Apr-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 21-Apr-2025 5:00 PM EDT Released to reporters: 15-Apr-2025 8:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Apr-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 21-Apr-2025 10:05 AM EDT
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors
Kowa Company Ltd.

Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced an upcoming presentation of non-clinical data for K-679, its novel antibody drug-loaded unimicelle conjugate (ADUC) with unprecedented drug loading capacity.

   
Ҵý: Comfortable in (bio)printed skin
Released: 17-Apr-2025 8:50 PM EDT
Comfortable in (bio)printed skin
University of Pretoria

Wound healing has been termed “an overlooked burden and a silent epidemic” due to the significant financial strain that it places on healthcare systems, let alone the unquantifiable human cost.

   
Released: 17-Apr-2025 1:10 PM EDT
GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility
GemPharmatech LLC

GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility

Ҵý: Wesley Sundquist Named to TIME’s Annual TIME100 List of the 100 Most Influential People in the World
Released: 17-Apr-2025 1:05 PM EDT
Wesley Sundquist Named to TIME’s Annual TIME100 List of the 100 Most Influential People in the World
University of Utah Health

Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection with 99.9% to 100% efficacy and could dramatically lower infection rates worldwide.

   
Ҵý: Direct-Acting Oral Anticoagulant and Antiseizure Medication Interactions: A Gray Zone in Epilepsy Treatment
Released: 17-Apr-2025 8:35 AM EDT
Direct-Acting Oral Anticoagulant and Antiseizure Medication Interactions: A Gray Zone in Epilepsy Treatment
International League Against Epilepsy

As many as 10% of people with epilepsy taking antiseizure medications also take medications to lower the risk of blood clots. Many are prescribed direct-acting oral anticoagulants, or DOACs. But how DOACs interact with antiseizure medications, particularly newer-generation medications, is still not clear.

Released: 15-Apr-2025 8:05 PM EDT
Inactive Components in Agricultural Runoff May Be Hidden Contributors to Drinking Water Hazards
Washington University in St. Louis

A new study from researchers in the at Washington University in St. Louis reveals the impact of what might may be precursors to harmful contaminants in drinking water, formed during water disinfection.

Released: 15-Apr-2025 5:20 PM EDT
You Can Heal More Wounds with Honey
Universite de Montreal

UdeM pharmacy professor Simon Matoori has reviewed studies on the therapeutic properties of honey in the treatment of both acute and chronic wounds.

Released: 14-Apr-2025 10:30 AM EDT
ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies
ProBio Inc.

ProBio, a global leader in the antibody discovery and development, is pleased to announce its upcoming poster presentation at the American Association for Cancer ResearchⓇ (AACR) 116th Annual Meeting, to be held April 25 to 30, 2025, at the McCormick Place Convention Center in Chicago, Illinois.

   
Ҵý: Study Provides Scaffold to Selectively Target Drug Breakdown Process
Released: 10-Apr-2025 8:05 PM EDT
Study Provides Scaffold to Selectively Target Drug Breakdown Process
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.



close
3.10597